Poges 2mg Capsule

Introduction

Poges is a prescription medication that contains the active ingredient Polmacoxib. It is available in the form of capsules and is primarily used for the treatment of certain medical conditions.

Uses

Poges is commonly prescribed to relieve pain and inflammation associated with conditions such as arthritis, osteoarthritis, and rheumatoid arthritis. It may also be used to manage pain after surgical procedures or injuries.

Dosage and Administration

The dosage of Poges may vary depending on the individual’s condition and medical history. Follow the instructions provided by your healthcare professional. Typically, the recommended dose is one capsule taken orally, with or without food, once or twice daily. Do not exceed the prescribed dosage unless directed by your doctor.

Mechanism of Action

Poges belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing the production of certain chemicals in the body that cause pain and inflammation. By inhibiting the activity of these chemicals, Poges helps to alleviate pain and improve mobility.

Side Effects

Common side effects may include stomach upset, nausea, dizziness, and headache. If these side effects persist or worsen, consult your healthcare provider. Serious side effects are rare, but they can occur. These may include allergic reactions, stomach bleeding, liver or kidney problems, and heart-related complications. Seek immediate medical attention if you experience any signs of a serious side effect.

Drug Interactions

Poges may interact with certain medications, including but not limited to other NSAIDs, blood thinners, corticosteroids, and certain antidepressants. These interactions can increase the risk of side effects or reduce the effectiveness of either medication. Inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.

Precautions

Before taking Poges, inform your healthcare provider about any allergies you have, as well as your medical history, especially if you have a history of stomach ulcers, bleeding disorders, liver or kidney disease, or heart conditions. Poges should be used with caution in individuals with underlying medical conditions. Avoid alcohol consumption while taking this medication, as it can increase the risk of stomach bleeding.

Storage

Patient Tips

• Take Poges exactly as prescribed by your healthcare provider.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not crush, chew, or break the capsules. Swallow them whole with a glass of water.
• If you experience any unusual symptoms or have concerns about the medication, consult your healthcare provider.
• attend regular follow-up appointments with your healthcare provider to monitor your response to the medication and make any necessary adjustments to your treatment plan.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Easwaran R, Mistry UK, Bhole M, Peethambaran K. Polmacoxib: A Review of the Newer Non-steroidal Anti-inflammatory Drug in Osteoarthritis. Cureus. 2024 Apr 17;16(4):e58446. doi: 10.7759/cureus.58446. eCollection 2024 Apr. [Accessed 25 Jun. 2024] Available at:
• Gu Y, Zhang Z, Wang YE, Dai Z, Yuan Y, Xiong D, Li J, Walsh PJ, Mao J. Benzylic Aroylation of Toluenes Mediated by a LiN(SiMe3)2/Cs+ System. J Org Chem. 2022 Jan 7;87(1):406-418. doi: 10.1021/acs.joc.1c02446. Epub 2021 Dec 27. [Accessed 18 Jun. 2024] Available at:
• Supuran CT. An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol. 2020 Apr;16(4):297-307. doi: 10.1080/17425255.2020.1743679. Epub 2020 Mar 21. [Accessed 19 Jun. 2024] Available at:
• Kim HT, Cha H, Hwang KY. Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649). Biochem Biophys Res Commun. 2016 Sep 9;478(1):1-6. doi: 10.1016/j.bbrc.2016.07.114. Epub 2016 Jul 27. [Accessed 6 Jun. 2024] Available at: